James Willis Hall

James Willis Hall is a declared insider of IMV Inc. (formerly Immunovaccine Inc.), with filings sourced from SEDI. Between 2 May 2018 and 2 January 2019, the trades on record add up to 4 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

On 14 January 2019 came the latest disclosure, an option exercise for €16k in IMV Inc. (formerly Immunovaccine Inc.). Typically, a trade is published a median of 12 days after it takes place. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.